Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Seock‐Ah Im

机构：Seoul National University, Seoul National University Hospital · ORCID：0000-0002-5396-6533

发表论文 1171 篇 · 总被引 72954 次 · h-index 100

代表论文

  • Ki-67 index and galectin-3 as surrogate markers for predicting disease-free survival in luminal-type breast carcinoma treated with neoadjuvant chemotherapy (2026 · Journal of Pathology and Translational Medicine)
  • Table 1 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
  • Table 3 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
  • Table 4 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
  • Table 2 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
  • Supplementary Table S5 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)